| Literature DB >> 29475532 |
Anita W Asgar1, Sandra Lauck2, Dennis Ko3, Laurie J Lambert4, Malek Kass5, Corey Adams6, Najaf Nadeem7, Garth H Oakes8, Faisal Alqoofi9, John G Webb2.
Abstract
Transcatheter aortic valve implantation (TAVI) is a disruptive technology that has dramatically changed the way clinicians care for patients with aortic stenosis. In 15 short years, this technology has progressed from first-in-human to the standard of care for high-risk and inoperable patients with aortic stenosis. In 2016 the Canadian Cardiovascular Society published the first ever report of quality of care for TAVI in Canada. This report provided multiple insights into evaluating such care delivered to Canadians and the challenges that lie ahead. In this article, we summarize these challenges and encourage cardiologists to join the call to arms for improving quality of TAVI care in Canada.Entities:
Mesh:
Year: 2017 PMID: 29475532 DOI: 10.1016/j.cjca.2017.11.007
Source DB: PubMed Journal: Can J Cardiol ISSN: 0828-282X Impact factor: 5.223